Likarski Savobi Mnn (Diosmin, Combinations; Tender - 127758262

Procurement Summary

Country: Ukraine

Summary: Likarski Savobi Mnn (Diosmin, Combinations; Lercanidipine; Valsartan, Amlodipine and Hydrochlorezide; Nebivolol; Rosuvastatin; Eplenone; Sermrapeptase;

Deadline: 11 Oct 2025

Posting Date: 08 Oct 2025

Other Information

Notice Type: Tender

TOT Ref.No.: 127758262

Document Ref. No.: UA-2025-10-08-005026-a

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: UAH 698900.5

CPV Classification

33600000 - Pharmaceutical products
33620000 - Medicinal products for the blood, blood-forming organs and the cardiovascular system
33630000 - Medicinal products for dermatology and the musculo-skeletal system
33610000 - Medicinal products for the alimentary tract and metabolism
33650000 - General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
33660000 - Medicinal products for the nervous system and sensory organs

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

Лікарські засоби МНН (Diosmin, combinations; Lercanidipine;Valsartan, amlodipine and hydrochlorothiazide; Nebivolol;Rosuvastatin;Eplerenone;Metoprolol;Serrapeptase; Thiocolchicoside;Pantoprazole;Vancomycin;Lidocaine; Ornidazole;Dextran; Ofloxacin; Mupirocin; Sulfamethoxazole and trimethoprim; Captopril and diuretics; mg, lekarnidipine, covered with a film sheath of 10 mg, lecarnidipine, covered with a film sheath of 20 mg, amlodipine/valsartan/hydrochlortiazide 5 MG/160 mg/12.5 mg tablets, amlodipine/valsartan 10 mg/160 mg tablets, nebivolol tablets of 5 mg, rowastatin tablets covered with a film sheath, 20 mg, rovastatin tablets, tablet, 10 mg, eupler, eupler. Serrateiopeptidase tablets covered with a shell, intestinal -soluble 10 mg, thiocolchycoside, solution for injection, 2 mg/ml, 2 ml, pantoprazole tablets of 20 mg, pantoprazole tablets of 40 mg, vancomycin lyophilisation/ %of infusions. For infusions, 5 mg/mg/mg, 100 ml, dextran 40 solution for infusions 100 mg/mg/ml 200 ml 200 ml, offloxacin, infloxacin solution for infusions 2 mg/ml/ml 200 ml, mupirocin, ointicin, ointment, 2 %, 15 g, 15 g, sulfamemethoxasazole/trimthmetoxazole/trimethetopex tablet, /80 mg, /80 mg. For an oral suspension 400 mg/57 mg in 5 ml, 70 ml vial

Documents

 Tender Notice